ARTICLE
7 April 2021

COVID-19 Key EU Developments, Policy & Regulatory Update No. 42

JD
Jones Day

Contributor

Jones Day is a global law firm with more than 2,500 lawyers across five continents. The Firm is distinguished by a singular tradition of client service; the mutual commitment to, and the seamless collaboration of, a true partnership; formidable legal talent across multiple disciplines and jurisdictions; and shared professional values that focus on client needs.
This regular update (no. 42 | 31 March 2021) covers key regulatory EU developments related to the evolving COVID-19 situation (Antitrust & State Aid; Trade/Export Controls; Medicines...
European Union Antitrust/Competition Law
Kaarli H. Eichhorn’s articles from Jones Day are most popular:
  • with Inhouse Counsel

This regular alert covers key regulatory EU developments related to the COVID-19 situation. It does not purport to provide an exhaustive overview of developments and contains no analysis or opinion.

LATEST KEY DEVELOPMENTS

Competition & State Aid

  • European Commission issues Comfort letter on Cooperation at a Matchmaking Event - Towards COVID19 vaccines upscale production
  • European Commission publishes Evaluation and follow-up measures on jurisdictional and procedural aspects of EU merger control
  • EU approves new and amended Member State measures to support the economy

Trade / Export Controls

  • European Commission reinforces transparency and authorization mechanism for exports of COVID-19 vaccines
  • EU-Canada pandemic recovery bolstered by Comprehensive Economic and Trade Agreement (CETA)

Medicines and Medical Devices

  • European Commission hosts first Matchmaking Event - Towards COVID-19 vaccines upscale production
  • EMA adopts recommendations to increase manufacturing capacity and supply of COVID-19 vaccines in the EU

Cybersecurity, Privacy & Data Protection

  • No noteworthy items for this issue

To view the full article, please click here.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

[View Source]

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More